Small molecule anti-genomic therapeutics
From Wikipedia, the free encyclopedia
Small molecule anti-genomic therapeutics, or SMAT, refers to a biodefense technology that targets DNA signatures found in many biological warfare agents. SMATs are new, broad-spectrum drugs that unify antibacterial, antiviral and anti-malarial activities into a single therapeutic that offers substantial cost benefits and logistic advantages for physicians and the military.
[edit] References
Levine, Daniel S. (2003). "Bio-defense company re-ups". San Francisco Business Times. Retrieved September 6, 2006.